NCT07227350 2026-03-10
L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)
Philogen S.p.A.
Phase 2 Not yet recruiting
Clinical Trials
8 trialsNCT07227870 2026-03-09
L19IL2/TNF in Patients With Basal Cell Carcinoma
Philogen S.p.A.
Phase 2 Not yet recruiting
NCT03567889 2025-12-17
NeoDREAM
Philogen S.p.A.
Phase 3 Recruiting
NCT06284590 2024-10-26
INTACT/MeRCI
Philogen S.p.A.
Phase 2 Recruiting
NCT02938299 2024-09-19
Pivotal
Philogen S.p.A.
Phase 3 Active not recruiting
NCT04362722 2023-10-10
DUNCAN
Philogen S.p.A.
Phase 2 Unknown
NCT05329792 2023-10-06
IntriNSiC
Philogen S.p.A.
Phase 2 Unknown
NCT02076633 2015-05-27
Intratumoral Administration of L19IL2/L19TNF
Philogen S.p.A.
Phase 2 Completed